Market Cap 5.34M
Revenue (ttm) 2.00M
Net Income (ttm) -3.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -153.00%
Debt to Equity Ratio 0.00
Volume 189,800
Avg Vol 1,832,966
Day's Range N/A - N/A
Shares Out 3.93M
Stochastic %K 0%
Beta 0.96
Analysts Strong Buy
Price Target $4.00

Company Profile

Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebi...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 327 8778
Address:
245 First Street, Riverview II, 18th Floor, Cambridge, United States
spinooch
spinooch Feb. 3 at 9:06 PM
$CYCN got smashed today
1 · Reply
traker1818
traker1818 Feb. 3 at 5:03 PM
$CYCN on the watch Watching Cyclerion Therapeutics; Zacks Small-Cap Research Gives Stock $8.00 Price Valuation
0 · Reply
Stoic_24
Stoic_24 Feb. 3 at 4:38 PM
$DRMA $CYCN Aaaaayynnd we’re off to another flying start on a Tuesday. Junk.
0 · Reply
StockTwitsGhost
StockTwitsGhost Feb. 3 at 5:14 AM
$CYCN @Mr_Pithy You’re not alone—we stand shoulder to shoulder, steady and unbreakable, like Templar knights holding the line together. “Analysts often initiate coverage ahead of a large capital raise such as a mixed shelf because the transaction creates a clear catalyst, fresh disclosures, and investor demand for research. Initiation helps frame the valuation, risks, and use of proceeds at a moment when new capital can materially change the company’s strategy and financial profile, while also supporting market visibility and liquidity during the offering.”
1 · Reply
Mr_Pithy
Mr_Pithy Feb. 2 at 9:59 PM
$CYCN ZacksSCR - CYCN Engineering A Reset; Initiating Coverage of Cyclerion Therapeutics, 02-02-26, By David Bautz PHD. “We are initiating coverage of Cyclerion Therapeutics, Inc. with a valuation of $8.00.” (See Zacks article-post below). Good luck 🍀 to all of us.
0 · Reply
Badger65
Badger65 Feb. 2 at 9:51 PM
$CYCN Little more volume and a little higher close, positive!!
1 · Reply
ZacksSCR
ZacksSCR Feb. 2 at 5:15 PM
$CYCN: Engineering a Reset; Initiating Coverage of Cyclerion Therapeutics… https://buff.ly/cvYjEqK
1 · Reply
Stoic_24
Stoic_24 Feb. 2 at 3:26 PM
$DRMA $CYCN in the pooper and circling the drain.
1 · Reply
ShortTheStock
ShortTheStock Feb. 2 at 12:41 PM
$CYCN heading below 0.9
0 · Reply
spinooch
spinooch Jan. 30 at 4:56 PM
$CYCN 1000 more.
1 · Reply
Latest News on CYCN
Cyclerion Therapeutics, Inc. - Pre Recorded Special Call

Sep 24, 2025, 12:53 PM EDT - 4 months ago

Cyclerion Therapeutics, Inc. - Pre Recorded Special Call


Regina Graul, Ph.D., Promoted to Chief Executive Officer

Aug 7, 2024, 7:00 AM EDT - 1 year ago

Regina Graul, Ph.D., Promoted to Chief Executive Officer


Cyclerion Appoints Regina Graul, Ph.D., as President

Dec 4, 2023, 8:00 AM EST - 2 years ago

Cyclerion Appoints Regina Graul, Ph.D., as President


Cyclerion Announces Reverse Stock Split

May 15, 2023, 1:00 PM EDT - 2 years ago

Cyclerion Announces Reverse Stock Split


spinooch
spinooch Feb. 3 at 9:06 PM
$CYCN got smashed today
1 · Reply
traker1818
traker1818 Feb. 3 at 5:03 PM
$CYCN on the watch Watching Cyclerion Therapeutics; Zacks Small-Cap Research Gives Stock $8.00 Price Valuation
0 · Reply
Stoic_24
Stoic_24 Feb. 3 at 4:38 PM
$DRMA $CYCN Aaaaayynnd we’re off to another flying start on a Tuesday. Junk.
0 · Reply
StockTwitsGhost
StockTwitsGhost Feb. 3 at 5:14 AM
$CYCN @Mr_Pithy You’re not alone—we stand shoulder to shoulder, steady and unbreakable, like Templar knights holding the line together. “Analysts often initiate coverage ahead of a large capital raise such as a mixed shelf because the transaction creates a clear catalyst, fresh disclosures, and investor demand for research. Initiation helps frame the valuation, risks, and use of proceeds at a moment when new capital can materially change the company’s strategy and financial profile, while also supporting market visibility and liquidity during the offering.”
1 · Reply
Mr_Pithy
Mr_Pithy Feb. 2 at 9:59 PM
$CYCN ZacksSCR - CYCN Engineering A Reset; Initiating Coverage of Cyclerion Therapeutics, 02-02-26, By David Bautz PHD. “We are initiating coverage of Cyclerion Therapeutics, Inc. with a valuation of $8.00.” (See Zacks article-post below). Good luck 🍀 to all of us.
0 · Reply
Badger65
Badger65 Feb. 2 at 9:51 PM
$CYCN Little more volume and a little higher close, positive!!
1 · Reply
ZacksSCR
ZacksSCR Feb. 2 at 5:15 PM
$CYCN: Engineering a Reset; Initiating Coverage of Cyclerion Therapeutics… https://buff.ly/cvYjEqK
1 · Reply
Stoic_24
Stoic_24 Feb. 2 at 3:26 PM
$DRMA $CYCN in the pooper and circling the drain.
1 · Reply
ShortTheStock
ShortTheStock Feb. 2 at 12:41 PM
$CYCN heading below 0.9
0 · Reply
spinooch
spinooch Jan. 30 at 4:56 PM
$CYCN 1000 more.
1 · Reply
defman
defman Jan. 30 at 2:39 PM
$CYCN Tick Tock Shortf**cks
0 · Reply
Stoic_24
Stoic_24 Jan. 28 at 4:43 PM
$CYCN Nice try bro… gonna need a whole lot more than memes to save your tail now.
1 · Reply
Thrand11
Thrand11 Jan. 28 at 4:40 PM
0 · Reply
skyrockets_Inc
skyrockets_Inc Jan. 28 at 3:10 PM
$CYCN Shorts are officially losing money. Paying 1% a day in fees and stock has flat-lined. Only a matter of days before they close positions IMO
1 · Reply
defman
defman Jan. 28 at 2:35 PM
0 · Reply
ShortTheStock
ShortTheStock Jan. 28 at 8:02 AM
$CYCN big bag here
1 · Reply
defman
defman Jan. 27 at 4:28 PM
0 · Reply
spinooch
spinooch Jan. 27 at 2:01 AM
$CYCN pretty boring around here. May snag 1000 more.
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW Jan. 27 at 12:48 AM
$CYCN shorts will get blown out hard here eventually, long patience will pay
0 · Reply
StockTwitsGhost
StockTwitsGhost Jan. 26 at 9:25 PM
$CYCN The rats paying 200-300% to scalp .02-.03. 😆 When volume and news hits it’ll be very very ugly for them.
1 · Reply
TradeMadeNow
TradeMadeNow Jan. 26 at 4:40 PM
$CYCN Bad news and good news on this one. This is low volume drop. Drop is the bad news. Low volume is the good news. Any kind of buying volume is more good news to move it back up.
0 · Reply
Thrand11
Thrand11 Jan. 26 at 3:12 PM
0 · Reply